跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
耐乐品 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ropivacaine Hydrochloride Injection
Approved
化学药品
Ropivacaine Hydrochloride Injection
Aspen Pharmacare Australia Pty Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Dec 31, 2024
Approval ID
8kEL9Z0haOb
Company
Aspen Pharmacare Australia Pty Ltd.
Type
化学药品
Approval Details
Approval Id
8kEL9Z0haOb
Approval Number
国药准字HJ20140766
Generic Name
盐酸罗哌卡因注射液
Generic Name En
Ropivacaine Hydrochloride Injection
Trade Name
耐乐品
Drug Type
化学药品
Dosage Form
注射剂
Strength
10ml:20mg
Reg Date
2024-12-31
Expired Date
2029-12-30
Company Name
Aspen Pharmacare Australia Pty Ltd.
Production Company Name
ASTRAZENECA AB
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Production Company Detail Path
/organization/astrazeneca-ab
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 31, 2024
Approval ID
8kEL9Z0haOb
Type
化学药品
Back to NMPA Approvals